- Asselineau, J. , & Lederer, E. (1950). Structure of the Mycolic acid of Mycobacteria. Nature , 166 , 782–783.10.1038/166782a0
- Banerjee, A. , Dubnau, E. , Quemard, A. , Balasubramanian, V. , Um, K. S. , Wilson, T. , … Jacobs, W. R. (1994). InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis . Science , 263 , 227–230.10.1126/science.8284673
- Dye, C. , Lönnroth, K. , Jaramillo, E. , Williams, B. G. , & Raviglione, M. (2009). Trends in tuberculosis incidence and their determinants in 134 countries. Bulletin of the World Health Organization , 87 , 683–691.10.2471/BLT.00.000000
- Funk, O. F. , Kettmann, V. , Drimal, J. , & Langer, T. (2004). Chemical function based pharmacophore generation of endothelin-a selective receptor antagonists. Journal of Medicinal Chemistry , 47 , 2750–2760.10.1021/jm031041j
- Halgren, A. , Murphy, B. , Friesner, R. A. , Beard, H. S. , Frye, L. L. , Pollard, W. T. , & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring 2. Enrichment factors in database screening. Journal of Medicinal Chemistry , 47 , 1750–1759.10.1021/jm030644s
- He, X. , Alian, A. , Stroud, R. , Ortiz, D. E. , & Montellano, P. R. (2006). Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis . Journal of Medicinal Chemistry , 49 , 6308–6323.10.1021/jm060715y
- He, X. , Alian, A. , Ortiz, D. E. , & Montellano, P. R. (2007). Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorganic & Medicinal Chemistry , 15 , 6649–6658.10.1016/j.bmc.2007.08.013
- Irwin, J. , Sterling, T. , Mysinger, M. , Bostand, S. , & Coleman, G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling , 52 , 1757–1768.10.1021/ci3001277
- Maestro v10.1 (2009). Glide . New York, NY : Schrodinger, LLC.
- Maria, C. S. , Marcus, V. N. , DeSouza, A. C. P. , Marcelle, D. L. , Rasnisb, B. , Cristina, M. , … Peralta, A. (2007). Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues. ARKIVOC , 15 , 181–191.
- Mason, J. S. , Good, A. C. , & Martin, E. J. (2001). 3D pharmacophore in drug discovery. Current Pharmaceutical Design , 7 , 567–597.10.2174/1381612013397843
- Mohsin, Y. L. , Anu, M. , Mohd, A. , & Prakash, C. J. (2017). Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies. Journal of Biomolecular Structure and Dynamics . doi:10.1080/07391102.2017.1372313
- Mohsin, Y. L. , Mohd., A. , Vivek, K. G. , & Prakash, C. J. (2017). Identification of Mycobacterium tuberculosis enoyl-acyl carrier proteinreductase inhibitors: A combined in-silico and in-vitro analysis. Journal of Molecular Graphics and Modelling , 76 , 172–180.
- Niu, M. , Dong, F. , Tang, S. , Fida, G. , Qin, J. , Qiu, J. , … Gu, Y. (2013). Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors. PLoS ONE , 8 (12), e82360.10.1371/journal.pone.0082360
- Podlogar, B. L. , & Ferguson, D. M. (2000). QSAR and CoMFA: A perspective on the practical application to drug discovery. Drug Des Discov , 17 , 4–12.
- Quemard, A. , Blanchard, J. S. , Jacobs, W. R. , & Sacchetini, J. C. (1995). Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis . Science , 267 , 1638–1641.
- Rao, G. S. , Vijaykrishnan, R. , & Kumar, M. (2008). Structure based design of novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: A Computer modelling approach. Chem. Biol. Drug. Des. , 72 , 444–449.
- Santo, D. , Fermeglia, M. , & Ferrone, M. (2005). Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. Journal of Medicinal Chemistry , 48 , 6304–6314.10.1021/jm0504454
- Shalini, S. , Maaged, A. , Dharmarajan, S. , & Lalitha, G. (2017). Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: Homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Journal of Biomolecular Structure & Dynamics . doi:10.1080/07391102.2017.1384398
- Sinosh, S. , Meghna, M. , & Nikhil, B. (2018). Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii – insights from molecular docking, molecular dynamic simulations and in vitro assays. Journal of Biomolecular Structure & Dynamics ,. doi:10.1080/07391102.2018.1451387
- Sivakumar, P. M. , Seenivasan, S. P. , Kumar, V. , & Doble, M. (2007). Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorganic & Medicinal Chemistry Letters , 17 , 1695–1700.10.1016/j.bmcl.2006.12.112
- Stover, C. K. , Warrener, P. , Van Devanter, D. R. , Sherman, D. R. , Arain, T. M. , Langhorne, M. H. , & Anderson, S. W. (2000). A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature , 405 , 962–966.10.1038/35016103
- Takayama, K. , Wang, C. , & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis . Clinical Microbiology Reviews , 18 , 81–101.10.1128/CMR.18.1.81-101.2005
- Tsukamura, M. , Wang, C. , & Besra, S. (1978). A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis. Kekkaku (Tuberculosis) , 53 , 495–498.
- Williams, P. , Floyd, K. , Dye, C. , Elzinga, G. , & Raviglione, M. (2005). Tuberculosis control in the era of HIV. Nature Reviews Immunology , 5 , 819–826.
- Yang, Y. , Xu, S. , Zhang, M. , Jin, R. , Zhang, L. , Bao, J. , & Wang, H. (2006). Purification and characterization of a functionally active Mycobacterium tuberculosis pyrroline-5-carboxylate reductase. Protein Expression and Purification , 45 , 241–248.10.1016/j.pep.2005.08.007
- Zhang, Y. , Heym, B. , Allen, B. , Young, D. , & Cole, S. (1992). The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis . Nature , 283 , 591593.
- Zhang, Y. , Garbe, T. , & Young, D. (1993). Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Molecular Microbiology , 8 , 521–524.10.1111/mmi.1993.8.issue-3
- Zhao, X. , Yu, H. , Yu, S. , Wang, F. , Sacchettini, J. C. , & Magliozzo, R. S. (2005). Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase−peroxidase (KatG) and its S315T. Mutant Biochemistry , 45 , 4131–4140.
Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.